Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 5Phase 1 4Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 9Glioma 7Brain Neoplasms 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Melanoma 3Lung Neoplasms 3Glioblastoma 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Neuroblastoma 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1

Interventions

Radiotherapy 2Methotrexate 2fluorodopa F 18 1etoposide phosphate 1Temozolomide 1Radiation 1Perfusion Magnetic Resonance Imaging 1Magnetic Resonance Spectroscopy 1Leucovorin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gadolinium DTPA 1Etoposide 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Biopsy 1Azacitidine 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ependymoma × Magnetic Resonance Spectroscopy × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡